| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |